Approved NMOSD Therapies
A new era of care: Exploring the four FDA-approved targeted therapies designed to prevent NMOSD relapses.
Soliris (eculizumab)
Enspryng (satralizumab-mwge)
Ultomiris (ravulizumab-cwvz)
Clinical Trials
Join the next wave of medical advancement by exploring current NMOSD clinical trial opportunities.
Clinicaltrials.gov
Explore the most comprehensive global database of privately and publicly funded clinical studies. This is the primary resource for searching current NMOSD trials, eligibility requirements, and study locations throughout the United States and abroad.
ClinicalTrials.eu
Access the official European Union register for clinical trials. This portal provides detailed information on interventional clinical trials authorized in the European Union and the European Economic Area, specifically highlighting research occurring across Europe.
Rare Disease Education – NORD® Learning
Enhance your understanding of the clinical research process through the National Organization for Rare Disorders. This educational hub offers patient-friendly guides on how trials work, what to expect as a participant, and the vital role of research in the rare disease community.